Search

everythinglearnresearchcommunity

for

Search:↓

Tissue environment greatly affects the unique epigenetic makeup of regulatory T cells, which could impact autoimmune disease treatment.

Researchers found four genes that could help diagnose severe alopecia areata early.

Patients with RASopathies are at risk for autoimmune disorders and should be routinely screened.

Activating Nrf2 helps wounds heal faster by increasing hair follicle stem cells.

Topical tofacitinib is effective in promoting hair growth for non-scarring alopecia.

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

Stopping JAK inhibitor treatment for hair loss can lead to worse hair loss than before the treatment.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

NK cells play a role in skin diseases like eczema and psoriasis.

Immune cells help regulate hair growth, and better understanding this can improve hair loss treatments.

New JAK inhibitor drugs show promise for treating skin diseases but need more research on safety and effectiveness.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

Hydroxypinacolone retinoate is a potent anti-aging ingredient for skin that is more effective and less irritating than other forms of retinoids.

PPAR-γ may be a key target for treating alopecia areata and other skin conditions.

Adipose-derived stem cells show potential for skin rejuvenation and wound healing but require more research to overcome challenges and ensure safety.

Baricitinib treatment for alopecia universalis can cause hair regrowth with unexpected whitening.

Blocking the protein CXCL12 with a specific antibody can increase hair growth in common hair loss conditions.

Fibroblast-derived growth factors and exosomes can significantly improve skin aging.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Most people with systemic lupus erythematosus have skin problems, and skin symptoms are often the first sign of the disease.

Vitamin D is important for skin health and may affect conditions like psoriasis and hair loss, but more research is needed to understand its role fully.

Oxidative stress plays a significant role in alopecia areata, and new treatments may include JAK inhibitors and antioxidants.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Inflammation plays a key role in activating skin stem cells for hair growth and wound healing, but more research is needed to understand how it directs cell behavior.

A protein from certain immune cells is key for new hair growth after skin injury in mice.

Unconventional lymphocytes are important for quick immune responses and healing of skin and mucosal barriers.

Alopecia areata needs more recognition and better treatment access in Latin America to improve patient care and outcomes.

Our microbiome may affect the development of the hair loss condition Alopecia Areata, but more research is needed to understand this relationship.